BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 25318879)

  • 1. Meta-analysis on radiofrequency ablation in combination with transarterial chemoembolization for the treatment of hepatocellular carcinoma.
    Cao JH; Zhou J; Zhang XL; Ding X; Long QY
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):692-700. PubMed ID: 25318879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
    Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
    World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
    Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
    Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: an up-to-date meta-analysis.
    Liu Z; Gao F; Yang G; Singh S; Lu M; Zhang T; Zhong Z; Zhang F; Tang R
    Tumour Biol; 2014 Aug; 35(8):7407-13. PubMed ID: 24777334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.
    Yan S; Xu D; Sun B
    Dig Dis Sci; 2013 Jul; 58(7):2107-13. PubMed ID: 23361576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
    Jiang C; Cheng G; Liao M; Huang J
    World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
    Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and Safety of Radiofrequency Ablation Combined with Transcatheter Arterial Chemoembolization for Hepatocellular Carcinomas Compared with Radiofrequency Ablation Alone: A Time-to-Event Meta-Analysis.
    Wang X; Hu Y; Ren M; Lu X; Lu G; He S
    Korean J Radiol; 2016; 17(1):93-102. PubMed ID: 26798221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis.
    Lan T; Chang L; Mn R; Wu L; Yuan YF
    Medicine (Baltimore); 2016 Apr; 95(15):e3185. PubMed ID: 27082558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of Survival Rate for Patients with Hepatocellular Carcinoma Using Transarterial Chemoembolization in Combination with Three-Dimensional Conformal Radiation Therapy: A Meta-Analysis.
    Bai H; Gao P; Gao H; Sun G; Dong C; Han J; Jiang G
    Med Sci Monit; 2016 May; 22():1773-81. PubMed ID: 27228411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization combination therapy vs monotherapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Li L; Tian J; Liu P; Wang X; Zhu Z
    Tumori; 2016 Jun; 2016(3):301-10. PubMed ID: 27002950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining transarterial chemoembolization with radiofrequency ablation for hepatocellular carcinoma.
    Jiang G; Xu X; Ren S; Wang L
    Tumour Biol; 2014 Apr; 35(4):3405-8. PubMed ID: 24277379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
    Wang W; Shi J; Xie WF
    Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effectiveness of radiofrequency ablation with or without transarterial chemoembolization for hepatocellular carcinoma.
    Kong QF; Jiao JB; Chen QQ; Li L; Wang DG; Lv B
    Tumour Biol; 2014 Mar; 35(3):2655-9. PubMed ID: 24197985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term Outcomes of Transcatheter Arterial Chemoembolization Combined With Radiofrequency Ablation as an Initial Treatment for Early-Stage Hepatocellular Carcinoma.
    Zhang YJ; Chen MS; Chen Y; Lau WY; Peng Z
    JAMA Netw Open; 2021 Sep; 4(9):e2126992. PubMed ID: 34570206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Transarterial Chemoembolization Combined with Radiofrequency Ablation Therapy
    Yi PS; Huang M; Zhang M; Xu L; Xu MQ
    Am Surg; 2018 Feb; 84(2):282-288. PubMed ID: 29580359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
    Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ
    Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of radiofrequency ablation with transarterial chemoembolization for hepatocellular carcinoma: a meta-analysis.
    Yan S; Xu D; Sun B
    Dig Dis Sci; 2012 Nov; 57(11):3026-31. PubMed ID: 22585384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Outcomes of Transarterial Chemoembolization Combined with Radiofrequency Ablation Versus Transarterial Chemoembolization Alone for Recurrent Hepatocellular Carcinoma After Surgical Resection.
    Song Q; Ren W; Fan L; Zhao M; Mao L; Jiang S; Zhao C; Cui Y
    Dig Dis Sci; 2020 Apr; 65(4):1266-1275. PubMed ID: 31312995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination transarterial chemoembolization and radiofrequency ablation therapy for early hepatocellular carcinoma.
    Song MJ; Bae SH; Lee JS; Lee SW; Song DS; You CR; Choi JY; Yoon SK
    Korean J Intern Med; 2016 Mar; 31(2):242-52. PubMed ID: 26874512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.